首页 | 本学科首页   官方微博 | 高级检索  
     

毛发红糠疹的治疗进展
引用本文:朱慧英,杨宝琦. 毛发红糠疹的治疗进展[J]. 中国麻风皮肤病杂志, 2022, 38(12): 918-923. DOI: 10.12144/zgmfskin202212918
作者姓名:朱慧英  杨宝琦
作者单位:山东第一医科大学附属皮肤病医院(山东省皮肤病医院),山东省皮肤病性病防治研究所,济南,250022
摘    要:毛发红糠疹病因及发病机制不明,通常对传统治疗抵抗。由于缺乏高质量的证据,目前尚无治疗指南,维A酸类药物被普遍作为一线治疗,近年来生物制剂被证明在严重难治性病例中有快速、显著的疗效。本文就PRP治疗方法进行综述。

关 键 词:毛发红糠疹  维A酸类药物  生物制剂

Update of the treatment of pityriasis rubra pilaris
ZHU Huiying,YANG Baoqi. Update of the treatment of pityriasis rubra pilaris[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(12): 918-923. DOI: 10.12144/zgmfskin202212918
Authors:ZHU Huiying  YANG Baoqi
Affiliation:Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250022, China
Abstract:The etiology and pathogenesis of pityriasis rubra pilaris remains unclear, and it is often resistant to conventional treatment. Due to the lack of high-quality evidence, there are currently no treatment guidelines. Retinoids are considered as first-line therapy, and in recent years biologics have been shown to have rapid and significant responses in severe refractory cases. The treatments of pityriasis rubra pilaris are reviewed.
Keywords:pityriasis rubra pilaris  retinoids  biologics  
点击此处可从《中国麻风皮肤病杂志》浏览原始摘要信息
点击此处可从《中国麻风皮肤病杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号